These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33644954)

  • 1. Recent Progress on Biomaterials Fighting against Viruses.
    Li S; Guo X; Gao R; Sun M; Xu L; Xu C; Kuang H
    Adv Mater; 2021 Apr; 33(14):e2005424. PubMed ID: 33644954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-based approaches in the development of antiviral agents and vaccines.
    Li Y; Xiao Y; Chen Y; Huang K
    Life Sci; 2021 Jan; 265():118761. PubMed ID: 33189824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graphene-based materials as nanoplatforms for antiviral therapy and prophylaxis.
    Iannazzo D; Giofrè SV; Espro C; Celesti C
    Expert Opin Drug Deliv; 2024 May; 21(5):751-766. PubMed ID: 38841752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress in Two-Dimensional Antimicrobial Nanomaterials.
    Miao H; Teng Z; Wang C; Chong H; Wang G
    Chemistry; 2019 Jan; 25(4):929-944. PubMed ID: 30030852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-based biomaterials for orthopaedic applications: Recent advances and future prospects.
    Kumar S; Nehra M; Kedia D; Dilbaghi N; Tankeshwar K; Kim KH
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110154. PubMed ID: 31753376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases.
    Homaeigohar S; Liu X; Elbahri M
    J Control Release; 2023 Jun; 358():476-497. PubMed ID: 37164241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections.
    Monroe MK; Wang H; Anderson CF; Jia H; Flexner C; Cui H
    J Control Release; 2022 Aug; 348():1028-1049. PubMed ID: 35752254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the smart metallic nanomaterials: advances in nanotechnology-based antimicrobials.
    Anyaegbunam NJ; Mba IE; Ige AO; Ogunrinola TE; Emenike OK; Uwazie CK; Ujah PN; Oni AJ; Anyaegbunam ZKG; Olawade DB
    World J Microbiol Biotechnol; 2024 Feb; 40(3):102. PubMed ID: 38366174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Properties of Alginate-Based Biomaterials: Promising Antiviral Agents against SARS-CoV-2.
    Serrano-Aroca Á; Ferrandis-Montesinos M; Wang R
    ACS Appl Bio Mater; 2021 Aug; 4(8):5897-5907. PubMed ID: 35006918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment.
    Dawre S; Maru S
    Life Sci; 2021 Aug; 278():119561. PubMed ID: 33915132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Antiviral Action of Alkaloids.
    Abookleesh FL; Al-Anzi BS; Ullah A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Inhibition Mechanism Mediated by Surface-Modified Silica Nanoparticles.
    de Souza E Silva JM; Hanchuk TD; Santos MI; Kobarg J; Bajgelman MC; Cardoso MB
    ACS Appl Mater Interfaces; 2016 Jul; 8(26):16564-72. PubMed ID: 27284685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiosemicarbazides: Updates on Antivirals Strategy.
    Moharana AK; Dash RN; Subudhi BB
    Mini Rev Med Chem; 2020; 20(20):2135-2152. PubMed ID: 32811412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping Membrane-Enveloped Viruses with Nanotechnology Strategies: Toward Antiviral Drug Development and Pandemic Preparedness.
    Yoon BK; Jeon WY; Sut TN; Cho NJ; Jackman JA
    ACS Nano; 2021 Jan; 15(1):125-148. PubMed ID: 33306354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of nanotechnology in virus detection, tracking, and infection mechanisms.
    Kang J; Tahir A; Wang H; Chang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1700. PubMed ID: 33511770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology Approaches in Chronic Wound Healing.
    Blanco-Fernandez B; Castaño O; Mateos-Timoneda MÁ; Engel E; Pérez-Amodio S
    Adv Wound Care (New Rochelle); 2021 May; 10(5):234-256. PubMed ID: 32320364
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent progress in biomaterials-driven ferroptosis for cancer therapy.
    Xiao N; Xiong S; Zhou Z; Zhong M; Bai H; Li Q; Tang Y; Xie J
    Biomater Sci; 2024 Jan; 12(2):288-307. PubMed ID: 38189655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharides and Their Derivatives as Potential Antiviral Molecules.
    Claus-Desbonnet H; Nikly E; Nalbantova V; Karcheva-Bahchevanska D; Ivanova S; Pierre G; Benbassat N; Katsarov P; Michaud P; Lukova P; Delattre C
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant-modified nanoclay exhibits an antiviral activity with high potency and broad spectrum.
    Liang JJ; Wei JC; Lee YL; Hsu SH; Lin JJ; Lin YL
    J Virol; 2014 Apr; 88(8):4218-28. PubMed ID: 24478435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.